Rula Abdulrahman - SUNY Research Connect

1 Finished
1 Active

IQVIA: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN)
Abdulrahman, R. (PI)
Alexion Pharmaceuticals Incorporated
08/12/24 → 01/29/27
Stony Brook University
Project: Research
COVID-19 Clinical Research: PPD Development: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Remdesivir in Participants with Severely Reduced Kidney Function...
Koraishy, F. (PI), Abdulrahman, R. (CoPI) & Go, R. (CoPI)
Gilead Sciences Incorporated
07/20/21 → 11/30/23
Stony Brook University
Project: Research